Advanced in Transient Ischemic Attack (TIA)

Otavio Berwanger

Av. Albert Einstein 627, 05651-90, 
Sao Paulo, SP, BR 
Advanced in Transient Ischemic Attack (TIA)
Av. Albert Einstein 627, 05651-90, 
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Otavio Berwanger practices in Sao Paulo, Brazil. Mr. Berwanger is rated as an Advanced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Acute Coronary Syndrome, COVID-19, Severe Acute Respiratory Syndrome (SARS), Percutaneous Coronary Intervention (PCI), and Gastric Bypass.

His clinical research consists of co-authoring 209 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Av. Albert Einstein 627, 05651-90, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Effect of Polipill on Patients at High Cardiovascular Risk : a Randomized Controlled Trial
Effect of Polipill on Patients at High Cardiovascular Risk : a Randomized Controlled Trial
Enrollment Status: Withdrawn
Publish Date: September 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension
Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension
Enrollment Status: Suspended
Publish Date: July 27, 2022
Intervention Type: Drug
Study Drugs: Indapamide+Losartan, Hyzaar®
Study Phase: Phase 3
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Enrollment Status: Completed
Publish Date: March 07, 2022
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 4
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Multicenter Clinical Trial to Assess the Effect of Atorvastatin in Patients With Acute Coronary Syndrome and Intended Percutaneous Coronary Intervention
A Randomized, Multicenter Clinical Trial to Assess the Effect of Atorvastatin in Patients With Acute Coronary Syndrome and Intended Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: June 17, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

208 Total Publications

Innovative design and modelling to improve sex and gender analysis in clinical trials.
Innovative design and modelling to improve sex and gender analysis in clinical trials.
Journal: BMJ (Clinical research ed.)
Published: October 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berwanger's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile